Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme (Q66034436)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme |
clinical trial |
Statements
Open Label Phase II Study On Glufosfamide Administered As A 60 Minute Infusion Every 3 Weeks In Recurrent Glioblastoma Multiforme (English)
0 references
January 2001
0 references
September 2001
0 references
32
0 references
18 year
0 references